A review of sleep-promoting medications used in pregnancy
Authors:
- 1 April 2015
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 212 (4) , 428-441
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Early Neurological Outcome of Young Infants Exposed to Selective Serotonin Reuptake Inhibitors during Pregnancy: Results from the Observational SMOK StudyPLOS ONE, 2013
- Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register studyBMJ Open, 2013
- Sleep duration and disorders in pregnancy: implications for glucose metabolism and pregnancy outcomesInternational Journal of Obesity, 2012
- Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use.Experimental and Clinical Psychopharmacology, 2012
- Sleep disturbances in depressed and nondepressed pregnant womenDepression and Anxiety, 2011
- Changes in sleep quality, but not hormones predict time to postpartum depression recurrenceJournal of Affective Disorders, 2011
- A Meta-analysis of Depression During Pregnancy and the Risk of Preterm Birth, Low Birth Weight, and Intrauterine Growth RestrictionArchives of General Psychiatry, 2010
- Self-reported short sleep duration and frequent snoring in pregnancy: impact on glucose metabolismAmerican Journal of Obstetrics and Gynecology, 2010
- How Disturbed Sleep May Be a Risk Factor for Adverse Pregnancy OutcomesObstetrical & Gynecological Survey, 2009
- Use of antihistamine medications during early pregnancy and isolated major malformationsBirth Defects Research Part A: Clinical and Molecular Teratology, 2009